093671132	093671132	CD	B-NP	O
|	|	NN	I-NP	O
AAH	AAH	NN	I-NP	O
|	|	NN	I-NP	O
79452355	79452355	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2975402	2975402	CD	B-NP	O
|	|	CC	I-NP	O
10/17/2006	10/17/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
noncardiac	noncardiac	JJ	I-NP	I-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
poorly	poorly	RB	B-NP	O
controlled	control	VBN	I-NP	O
DM	DM	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/17/2006	3/17/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/23/2006	7/23/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
ROSEBERRY	ROSEBERRY	NN	B-NP	O
,	,	,	O	O
ANDREA	ANDREA	NN	B-NP	O
252-22-56-7	252-22-56-7	CD	I-NP	O
Hi	Hi	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
2/18/06	2/18/06	CD	B-NP	O
AT	AT	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
Attending	Attend	VBG	B-VP	O
evaluation	evaluation	NN	B-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BLEWS	BLEWS	NNP	B-NP	O
,	,	,	O	O
LESLEY	LESLEY	NNP	B-NP	O
T.	T.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
J.D.	J.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
81	81	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
ATENOLOL	ATENOLOL	NNP	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
100	100	CD	B-NP	O
,	,	,	O	O
HR	HR	NN	B-NP	O
<	<	SYM	B-VP	O
60	60	CD	B-NP	O
DOVONEX	DOVONEX	NN	I-NP	O
OINT	OINT	NN	I-NP	O
0.005	0.005	CD	B-NP	O
%	%	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CALCIPOTRIENE	CALCIPOTRIENE	NN	I-NP	O
0.005	0.005	CD	B-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CREAM	CREAM	NN	I-NP	O
TP	TP	NN	I-NP	O
BID	BID	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
apply	apply	VB	B-VP	O
to	to	TO	B-PP	O
psoriatic	psoriatic	JJ	B-NP	O
lesions	lesion	NNS	I-NP	O
Number	Number	NNP	B-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
LANTUS	LANTUS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
35	35	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
2/29	2/29	CD	I-NP	O
-RRB-	-RRB-	SYM	O	O
LISINOPRIL	LISINOPRIL	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
DAILY	DAILY	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
100	100	CD	B-NP	O
ATIVAN	ATIVAN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
LORAZEPAM	LORAZEPAM	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
0.5	0.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q6H	Q6H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Insomnia	Insomnia	NNP	I-NP	O
,	,	,	O	O
Anxiety	Anxiety	NNP	B-NP	O
METFORMIN	METFORMIN	NNP	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
ZOCOR	ZOCOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
2/29	2/29	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/18/06	2/18/06	CD	B-NP	O
by	by	IN	B-PP	O
DARO	DARO	NNP	B-NP	O
,	,	,	O	O
HASSAN	HASSAN	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
MULTIVITAMIN	MULTIVITAMIN	NN	I-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
MULTIVI	MULTIVI	NN	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
2/18/06	2/18/06	CD	B-NP	O
by	by	IN	B-PP	O
KOEPPL	KOEPPL	NN	B-NP	O
,	,	,	O	O
HARVEY	HARVEY	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ZOCOR	ZOCOR	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
160129199	160129199	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
PCP	PCP	NN	B-NP	O
DR	DR	NN	I-NP	O
BREAUX	BREAUX	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
553	553	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
929-1843	929-1843	CD	I-NP	O
7/17/06	7/17/06	CD	I-NP	O
@	@	NN	I-NP	O
10	10	CD	I-NP	O
:	:	:	O	O
40	40	CD	B-NP	O
AM	AM	NN	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
r/o	r/o	NN	B-NP	O
MI	MI	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
noncardiac	noncardiac	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
poorly	poorly	RB	B-NP	O
controlled	control	VBN	I-NP	O
DM	DM	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
HTN	HTN	NN	I-NP	O
,	,	,	O	O
poorly	poorly	RB	B-VP	O
controlled	control	VBN	I-VP	O
type	type	NN	B-NP	O
II	II	CD	I-NP	O
DM	DM	NN	I-NP	O
x	x	SYM	B-NP	O
10	10	CD	B-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
psoriasis	psoriasis	NN	B-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Exercise	Exercise	NNP	I-NP	O
Stress	Stress	NNP	I-NP	O
Test	Test	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
high	high	JJ	B-NP	O
sugars/atypical	sugars/atypical	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
--	--	:	O	O
HPI	HPI	NN	B-NP	O
:	:	:	O	O
56	56	CD	B-NP	O
yo	yo	NN	I-NP	O
DM	DM	NN	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
poorly	poorly	RB	B-NP	O
controlled	control	VBN	I-NP	O
sugars	sugar	NNS	I-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
atypical	atypical	JJ	B-NP	O
CP	CP	NN	I-NP	B-DNA
and	and	CC	I-NP	O
hyperglycemia	hyperglycemia	NN	I-NP	O
x	x	SYM	B-NP	O
several	several	JJ	B-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
USH	USH	NN	I-NP	O
when	when	WRB	B-ADVP	O
,	,	,	O	O
around	around	IN	B-PP	O
noon	noon	RB	B-ADVP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
found	find	VBD	B-VP	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugar	sugar	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
520	520	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
symptoms	symptom	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
sweating	sweating	NN	B-NP	O
,	,	,	O	O
tremor	tremor	NN	B-NP	O
,	,	,	O	O
blurry	blurry	NN	B-NP	O
vision	vision	NN	I-NP	O
,	,	,	O	O
HA	HA	NN	B-NP	O
,	,	,	O	O
N/V	N/V	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
several	several	JJ	I-NP	O
months	month	NNS	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
which	which	WDT	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
radiate	radiate	VB	I-VP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pain	pain	NN	I-NP	O
usually	usually	RB	B-ADVP	O
comes	come	VBZ	B-VP	O
on	on	RP	B-PRT	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning/at	morning/at	NN	I-NP	O
rest	rest	NN	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
increased	increase	VBN	I-VP	O
in	in	IN	B-PP	O
frequency	frequency	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
N/V/diaphoresis	N/V/diaphoresis	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
HTn	HTn	NN	B-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
smoke	smoke	VB	I-VP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
family	family	NN	I-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
ACS	ACS	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
hyperchol	hyperchol	NN	B-NP	O
In	In	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
VSS	VSS	NNP	I-NP	O
and	and	CC	I-NP	O
BS	BS	NNP	I-NP	O
was	be	VBD	B-VP	O
400s	400s	CD	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
was	be	VBD	B-VP	O
WNL	WNL	NNP	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
give	give	JJ	B-NP	O
nitro	nitro	NN	I-NP	O
,	,	,	O	O
ASA	ASA	NN	B-NP	O
,	,	,	O	O
lopressor	lopressor	NN	B-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
,	,	,	O	O
ativan	ativan	NN	B-NP	O
and	and	CC	O	O
mag	mag	NN	B-NP	O
gluconate	gluconate	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
and	and	CC	O	O
sent	send	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
PMH	PMH	NN	B-NP	O
:	:	:	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
psoriasis	psoriasis	NN	B-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	B-protein
II	II	CD	I-NP	I-protein
x	x	CC	I-NP	O
10	10	CD	I-NP	O
yrs	yr	NNS	I-NP	O
--	--	:	O	O
SHx	SHx	NN	B-NP	O
:	:	:	O	O
former	former	JJ	B-NP	O
janitor	janitor	NN	I-NP	O
.	.	.	O	O

From	From	IN	B-PP	O
Pa	Pa	NNP	B-NP	O
Bay	Bay	NNP	I-NP	O
Ward	Ward	NNP	I-NP	O
3-4	3-4	CD	I-NP	O
beers	beer	NNS	I-NP	O
1-2x	1-2x	NN	I-NP	O
/	/	SYM	O	O
week	week	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
smoking	smoking	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
drugs	drug	NNS	I-NP	O
--	--	:	O	O
Fam	Fam	NNP	B-NP	O
Hx	Hx	NNP	I-NP	O
:	:	:	O	O
sister-DM	sister-DM	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
CAD	CAD	NN	I-NP	B-protein
--	--	:	O	O
All	All	DT	B-NP	O
:	:	:	I-NP	O
NKDA	NKDA	NN	I-NP	B-protein
--	--	:	O	O
Meds	Med	NNS	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
:	:	:	O	O
ASA	ASA	NN	B-NP	O
81	81	CD	I-NP	O
,	,	,	O	O
metformin	metformin	NN	B-NP	O
1000	1000	CD	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
vit	vit	NN	B-NP	B-protein
B1	B1	NN	I-NP	I-protein
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
50	50	CD	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
vit	vit	NN	B-NP	B-DNA
E	E	NNP	B-NP	I-DNA
,	,	,	O	O
lantus	lantus	NNP	B-NP	O
30U	30U	NNP	I-NP	O
qAM	qAM	NN	I-NP	O
,	,	,	O	O
ativan	ativan	NN	B-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
qHS	qHS	NN	I-NP	O
prn	prn	NN	I-NP	O
insomnia	insomnia	NN	I-NP	O
,	,	,	O	O
dovonex	dovonex	NN	B-NP	O
0.005	0.005	CD	I-NP	O
%	%	NN	I-NP	O
cream	cream	NN	I-NP	O
--	--	:	O	O
Daily	Daily	JJ	B-NP	O
status	status	NN	I-NP	O
VS	VS	NN	I-NP	O
:	:	:	O	O
98.1	98.1	CD	B-NP	O
76142/90	76142/90	CD	I-NP	O
20	20	CD	I-NP	O
98	98	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
Gen	Gen	NN	I-NP	O
:	:	:	O	O
NAD	NAD	NN	B-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
S1	S1	NN	B-NP	B-protein
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
S4	S4	NN	B-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
M/R/G	M/R/G	NNP	I-NP	O
Pulm	Pulm	NNP	I-NP	O
:	:	:	O	O
CTA	CTA	NN	B-NP	O
B	B	NN	I-NP	O
Abd	Abd	NN	I-NP	O
:	:	:	O	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
NT	NT	NN	I-NP	O
,	,	,	O	O
ND	ND	NN	B-NP	O
,	,	,	O	O
+	+	SYM	B-NP	O
BS	BS	NNP	I-NP	O
Ext	Ext	NNP	I-NP	O
:	:	:	O	O
WWP	WWP	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
C/C/E	C/C/E	NN	I-NP	B-protein
--	--	:	O	O
Labs/Tests	Labs/Test	NNS	B-NP	O
:	:	:	O	O
Cardiac	Cardiac	JJ	B-NP	O
enzymes	enzyme	NNS	I-NP	O
neg	neg	NN	I-NP	O
,	,	,	O	O
besides	besides	IN	B-PP	O
sugar	sugar	NN	B-NP	O
,	,	,	O	O
other	other	JJ	B-NP	O
labs	lab	NNS	I-NP	O
WNL	WNL	NNP	I-NP	O
CXR	CXR	NN	I-NP	B-protein
:	:	:	O	O
old	old	JJ	B-NP	O
L.	L.	NNP	I-NP	O
sided	sided	JJ	I-NP	O
rib	rib	NN	I-NP	O
fxs	fx	NNS	I-NP	O
.	.	.	O	O
?	?	.	O	O

new	new	JJ	B-NP	O
left	left	JJ	I-NP	O
rib	rib	NN	I-NP	O
fx	fx	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
acute	acute	JJ	I-NP	O
cardiopulm	cardiopulm	NN	I-NP	O
.	.	.	O	O

process	process	NN	B-NP	O
EKG	EKG	NN	I-NP	O
:	:	:	O	O
NSR	NSR	NN	B-NP	B-protein
.	.	.	O	O

--	--	:	O	O
A/P	A/P	NN	B-NP	O
56	56	CD	I-NP	O
yo	yo	NN	I-NP	O
Type	Type	NN	I-NP	O
II	II	CD	I-NP	O
DM	DM	NN	I-NP	O
with	with	IN	B-PP	O
poorly	poorly	RB	B-NP	O
controlled	control	VBN	I-NP	O
sugars	sugar	NNS	I-NP	O
with	with	IN	B-PP	O
atypical	atypical	JJ	B-NP	O
CP	CP	NN	I-NP	B-DNA
and	and	CC	O	O
asymtomatic	asymtomatic	JJ	B-NP	O
hyperglycemia	hyperglycemia	NN	I-NP	O
to	to	TO	B-PP	O
520	520	CD	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
ETT	ETT	NN	B-NP	B-DNA
,	,	,	O	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
exercise	exercise	VB	I-VP	O
only	only	RB	B-NP	O
2	2	CD	I-NP	O
'	'	SYM	I-NP	O
42	42	CD	I-NP	O
''	''	''	O	O
on	on	IN	B-PP	O
Standard	Standard	NNP	B-NP	O
Bruce	Bruce	NNP	I-NP	O
protocol	protocol	NN	I-NP	O
,	,	,	O	O
achieving	achieve	VBG	B-VP	O
HR	HR	NN	B-NP	O
of	of	IN	B-PP	O
130	130	CD	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
on	on	IN	B-PP	O
atenolol	atenolol	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
--	--	:	O	O
stopped	stop	VBD	B-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
leg	leg	NN	B-NP	O
fatigue	fatigue	NN	I-NP	O
and	and	CC	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

--	--	:	B-LST	O
1	1	LS	B-LST	O
.	.	.	O	O

CV	CV	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
P	P	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
?	?	.	O	O

LVH	LVH	NN	B-NP	O
on	on	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
exam	exam	NN	I-NP	O
.	.	.	O	O

no	no	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
.	.	.	O	O

Continued	Continue	VBN	B-NP	O
b-blocker	b-blocker	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
I	I	PRP	B-NP	O
-RRB-	-RRB-	VBP	B-VP	O
CP	CP	NN	B-NP	B-DNA
atypical	atypical	JJ	B-ADJP	O
for	for	IN	B-PP	O
ACS	ACS	NN	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
wnl	wnl	NN	I-NP	O
.	.	.	O	O

Ruled	Rule	VBN	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
.	.	.	O	O

Added	Add	VBN	B-NP	O
ACE	ACE	NN	I-NP	O
and	and	CC	I-NP	O
statin	statin	NN	I-NP	O
to	to	TO	B-PP	O
regimen	regimen	NN	B-NP	O
,	,	,	O	O
given	give	VBN	B-PP	O
ongoing	ongoe	VBG	B-VP	O
cardiac	cardiac	JJ	B-NP	B-protein
risk	risk	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
,	,	,	O	O
poorly	poorly	RB	B-VP	O
controlled	control	VBN	I-VP	O
DM	DM	NN	B-NP	O
.	.	.	O	O

-LRB-	-LRB-	HYPH	B-NP	O
R	R	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-VP	O
no	no	DT	B-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Endo	Endo	AFX	B-NP	B-protein
-	-	HYPH	I-NP	O
Type	Type	NN	B-NP	B-protein
II	II	CD	I-NP	I-protein
DM	DM	NN	I-NP	I-protein
with	with	IN	B-PP	O
poorly	poorly	RB	B-NP	O
controlled	control	VBN	I-NP	O
sugars	sugar	NNS	I-NP	O
.	.	.	O	O

Lantus	Lantus	NNP	B-NP	O
lowered	lower	VBD	B-VP	O
first	first	JJ	B-NP	O
night	night	NN	I-NP	O
because	because	IN	B-SBAR	O
NPO	NPO	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
30	30	CD	I-NP	O
U	U	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Gave	Gave	VB	B-VP	O
insulin	insulin	NN	B-NP	O
SS	SS	NN	I-NP	O
and	and	CC	O	O
4	4	CD	B-NP	O
mg	mg	NN	I-NP	O
qAC	qAC	NN	I-NP	O
.	.	.	O	O

Continued	Continue	VBN	B-NP	O
metformin	metformin	NN	I-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
discharge	discharge	VB	I-VP	O
on	on	IN	B-PP	O
35U	35U	NN	B-NP	O
lantus	lantus	NN	I-NP	O
qAM	qAM	NN	I-NP	O
,	,	,	O	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
f/u	f/u	VB	I-VP	O
with	with	IN	B-PP	O
PCP	PCP	NN	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Agyeman	Agyeman	NNP	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
titration	titration	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Skin	Skin	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
continue	continue	JJ	I-NP	O
dovonex	dovonex	NN	I-NP	O
for	for	IN	B-PP	O
psoriasis	psoriasis	NN	B-NP	B-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

Neuro	Neuro	AFX	O	B-cell_type
-	-	HYPH	O	O
?	?	.	O	O

anxiety	anxiety	NN	B-NP	O
.	.	.	O	O

continue	continue	VB	B-VP	O
ativan	ativan	NN	B-NP	O
PRN	PRN	NN	I-NP	O
for	for	IN	B-PP	O
insomnia	insomnia	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
EtOH	EtOH	NN	B-NP	O
withdrawal	withdrawal	NN	I-NP	O
during	during	IN	B-PP	O
hospitalization	hospitalization	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
-	-	HYPH	I-NP	O
low	low	JJ	I-NP	O
salt	salt	NN	I-NP	O
,	,	,	O	O
ADA	ADA	NN	B-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Ppx	Ppx	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
lovenox	lovenox	NN	I-NP	O
Contact	Contact	NN	I-NP	O
:	:	:	O	O
8661566191	8661566191	CD	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
family	family	NN	I-NP	O
member	member	NN	I-NP	O
number	number	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
FULL	FULL	NN	I-NP	O
CODE	CODE	NN	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Regresa	Regresa	NN	B-NP	O
al	al	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
para	para	NN	I-NP	O
presion	presion	NN	I-NP	O
o	o	NN	I-NP	O
dolor	dolor	NN	I-NP	O
del	del	NN	I-NP	O
pecho	pecho	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
KNAUF	KNAUF	NNP	B-NP	O
,	,	,	O	O
VALENTIN	VALENTIN	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CA94	CA94	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
2/18/06	2/18/06	CD	I-NP	O
@	@	SYM	I-NP	O
03	03	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

